Human Papilloma Virus (HPV) self-sampling promises to make the process of screening for cervical cancer easier, more ...

What it’s looking like is a stabilization” and, hopefully, a decline will follow, state epidemiologist Dr. Rachel Herlihy ...

A Halifax company is making progress in the fight against infectious diseases. MedMira’s newly manufactured HIV-Syphilis ...

This FDA-authorized Antigen test requires only one test to get results in 15 minutes using a nasal swab. If you want a test that’s even more reliable but you don’t want to leave the comfort of ...

The approval of the ITA is an important step towards getting the Multiplo® Complete Syphilis (TP/nTP) Antibody Test licensed and into the Canadian market. MedMira offers the only commercially ...

from Health Canada to begin clinical trials for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP), a cutting edge device that can determine active and non-active syphilis.

How can DNA from a cheek swab determine if someone is closely related to you? When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. DNA tests can ...

Australia will have the chance to defend their World Test Championship crown, claiming victory over India in the fifth and final Border-Gavaskar Test to secure their place in the Final at Lord's in ...

"But now that we have a simple nasal swab test to detect other endotypes, we can start to move the needle on developing biologics for (T2-low) disease." Researchers find clues to vaccine ...

The history of syphilis has long been debated, with experts unable to come to a consensus over the origins of the outbreak that rocked Europe in the 16th century. New research reveals the bacterium ...

PITTSBURGH (KDKA) - University of Pittsburgh researchers have developed a new nasal swab test to determine Asthma subtype results for kids. The study which was conducted by Dr. Juan Celedón a ...

“But now that we have a simple nasal swab test to detect other endotypes, we can start to move the needle on developing biologics for (T2-low) disease.” Researchers find clues to vaccine ...